Welcome
NEURONAX is a privately-held biotechnological company focusing on the development of technologies supporting neural repair in order to treat traumatic or severe degenerative disorders of the central nervous system (CNS) and contribute to improve neurological function, and then quality of life of patients.
NEURONAX aims at establishing « proof-of-concept », forming strategic alliances with partners and out-licenses agreements with biotechnology and pharmaceutical companies.
Moreover, the expertise of NEURONAX allows the enrichment of its portfolio of technologies and is also proposed outside in the form of contracts of service or contracts of research.